Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Farxiga® (dapagliflozin) – First-time authorized brand alternative

January 3, 2024 - Prasco launched an authorized brand alternative of Astra Zeneca’s Farxiga (dapagliflozin) tablets.

Download PDF

Rx navigation